Lantern Pharma Inc. fell 13.7% on Friday, November 20, 2026, on 234,152 shares. No headline about LTRN came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
Lantern Pharma Inc. (LTRN:NASDAQ) closed at $0.245 on November 20, 2026, down 13.73% on the day. The stock trades 94.4% below its 52-week high of $4.34 and 7.2% above its 52-week low of $0.229. Over the past year, it lost 91.9%. Lantern Pharma Inc. is part of the Health Care sector.
In 252 trading sessions since November 20, 2025, LTRN closed higher on 98 days (39%). Its best day was May 14, 2026 (+24.70%) and its worst was March 27, 2026 (-46.41%). The stock moved 10% or more in a single session 30 times.
Lantern Pharma Inc is a clinical-stage biotechnology company. It is focused on leveraging artificial intelligence machine learning and genomic data to streamline the drug development process and to identify the patients that will benefit from targeted oncology therapies. The firm's pipeline of development programs involves three small molecule drug candidates namely LP-100, LP-184, and LP-300.
Find more stocks like LTRN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.